Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 1
2008 1
2009 7
2010 3
2011 3
2012 4
2013 9
2014 2
2015 8
2016 10
2017 24
2018 23
2019 40
2020 44
2021 80
2022 88
2023 98
2024 126
2025 237
2026 150

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

811 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Battelino T, et al. Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Diabetes Care. 2019. PMID: 31177185 Free PMC article. Review.
Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous glucose monitoring (CGM). However, successful utilization of CGM technology in routine clinical practice remains relatively l …
Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous …
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
Jancev M, Vissers TACM, Visseren FLJ, van Bon AC, Serné EH, DeVries JH, de Valk HW, van Sloten TT. Jancev M, et al. Diabetologia. 2024 May;67(5):798-810. doi: 10.1007/s00125-024-06107-6. Epub 2024 Feb 16. Diabetologia. 2024. PMID: 38363342 Free PMC article.
We included RCTs investigating real-time CGM (rtCGM) or intermittently scanned CGM (isCGM) compared with self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes. ...Change in HbA(1c) and the CGM metrics time in range (TIR), …
We included RCTs investigating real-time CGM (rtCGM) or intermittently scanned CGM (isCGM) compared with self-monitorin …
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
Martens T, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, Pop-Busui R, Philis-Tsimikas A, Bao S, Umpierrez G, Davis G, Kruger D, Bhargava A, Young L, McGill JB, Aleppo G, Nguyen QT, Orozco I, Biggs W, Lucas KJ, Polonsky WH, Buse JB, Price D, Bergenstal RM; MOBILE Study Group. Martens T, et al. JAMA. 2021 Jun 8;325(22):2262-2272. doi: 10.1001/jama.2021.7444. JAMA. 2021. PMID: 34077499 Free PMC article. Clinical Trial.
Key secondary outcomes were CGM-measured time in target glucose range of 70 to 180 mg/dL, time with glucose level at greater than 250 mg/dL, and mean glucose level at 8 months. ...In the CGM group, compared with the BGM group, the mean pe …
Key secondary outcomes were CGM-measured time in target glucose range of 70 to 180 mg/dL, time with gluco …
Time in Range and Pregnancy Outcomes in People with Diabetes Using Continuous Glucose Monitoring.
Fishel Bartal M, Ashby Cornthwaite JA, Ghafir D, Ward C, Ortiz G, Louis A, Cornthwaite J, Chauhan SSP, Sibai BM. Fishel Bartal M, et al. Am J Perinatol. 2023 Apr;40(5):461-466. doi: 10.1055/a-1904-9279. Epub 2022 Jul 20. Am J Perinatol. 2023. PMID: 35858653
Among people with diabetes, 50% reached the recommended time in range using CGM.. . Time in range >70% was associated with reducing the rate of some neonatal complications.. . Time in range 70% was associated with increased ris …
Among people with diabetes, 50% reached the recommended time in range using CGM.. . Time in range >70% …
Continuous Glucose Monitoring Systems in Noninsulin-Treated People with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ferreira ROM, Trevisan T, Pasqualotto E, Chavez MP, Marques BF, Lamounier RN, van de Sande-Lee S. Ferreira ROM, et al. Diabetes Technol Ther. 2024 Apr;26(4):252-262. doi: 10.1089/dia.2023.0390. Epub 2024 Feb 13. Diabetes Technol Ther. 2024. PMID: 38090767
Four trials used real-time CGM (rt-CGM) and two intermittent scanning CGM (is-CGM). Compared with SMBG, CGM significantly reduced the glycated hemoglobin level (WMD -0.31%; 95% CI -0.42 to -0.21; I(2) = 0%), glucose level (WMD -11.16 mg/d …
Four trials used real-time CGM (rt-CGM) and two intermittent scanning CGM (is-CGM). Compared with SMBG, …
Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Uhl S, Choure A, Rouse B, Loblack A, Reaven P. Uhl S, et al. J Clin Endocrinol Metab. 2024 Mar 15;109(4):1119-1131. doi: 10.1210/clinem/dgad652. J Clin Endocrinol Metab. 2024. PMID: 37987208 Free article.
PURPOSE: To provide a systematic review and meta-analysis synthesizing the findings of randomized controlled trials (RCTs) of continuous glucose monitors (CGMs) in the management of adults with type 2 diabetes mellitus (T2DM) on glucose control and clinical outcomes. METHO …
PURPOSE: To provide a systematic review and meta-analysis synthesizing the findings of randomized controlled trials (RCTs) of continuous glu …
Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study.
Shah VN, DuBose SN, Li Z, Beck RW, Peters AL, Weinstock RS, Kruger D, Tansey M, Sparling D, Woerner S, Vendrame F, Bergenstal R, Tamborlane WV, Watson SE, Sherr J. Shah VN, et al. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4356-4364. doi: 10.1210/jc.2018-02763. J Clin Endocrinol Metab. 2019. PMID: 31127824 Free PMC article.
OBJECTIVE: To establish reference sensor glucose ranges in healthy, nondiabetic individuals across different age groups using a current generation CGM sensor. ...INTERVENTION: Each participant wore a blinded Dexcom G6 CGM, with once-daily calibration, for up …
OBJECTIVE: To establish reference sensor glucose ranges in healthy, nondiabetic individuals across different age groups using a curre …
Time in range centered diabetes care.
Dovc K, Battelino T. Dovc K, et al. Clin Pediatr Endocrinol. 2021;30(1):1-10. doi: 10.1297/cpe.30.1. Epub 2021 Jan 5. Clin Pediatr Endocrinol. 2021. PMID: 33446946 Free PMC article. Review.
For the majority of people with type 1 or type 2 diabetes, time in range (between 70 and 180 mg/dL, or 3.9 and 10 mmol/L) target of more than 70% is recommended, with each incremental increase of 5% towards this target being clinically meaningful. At the same tim …
For the majority of people with type 1 or type 2 diabetes, time in range (between 70 and 180 mg/dL, or 3.9 and 10 mmol/L) targ …
Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial.
Lind N, Christensen MB, Hansen DL, Nørgaard K. Lind N, et al. Diabetes Care. 2024 May 1;47(5):881-889. doi: 10.2337/dc23-2194. Diabetes Care. 2024. PMID: 38489032 Clinical Trial.
Primary outcome was between-group differences in change in time in range (TIR) 3.9-10.0 mmol/L, assessed at baseline, after 6 and 12 months by blinded CGM. The prespecified secondary outcomes were differences in change in several other glycemic, …
Primary outcome was between-group differences in change in time in range (TIR) 3.9-10.0 mmol/L, assessed at baseline, a …
Time in range measurements for hyperglycemia management during pregnancy.
Wang S, Xin H, Li L, Li P. Wang S, et al. Clin Chim Acta. 2022 Jun 1;531:56-61. doi: 10.1016/j.cca.2022.03.017. Epub 2022 Mar 23. Clin Chim Acta. 2022. PMID: 35339452 Review.
The prevalence of adverse pregnancy outcomes associated with poor glycemic control are increasing. Accordingly, effective blood glucose monitoring during pregnancy has become a subject of intense interest. Continuous glucose monitoring (CGM) displays dynamic changes …
The prevalence of adverse pregnancy outcomes associated with poor glycemic control are increasing. Accordingly, effective blood gluco …
811 results